ACTIVE

Danis Pharma

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

71,7 k €

-12.9% YoY

Gross margin

113,6 k €

-8.8% YoY

Equity

784,1 k €

+10.1% YoY

What does Danis Pharma do?

Danis Pharma is a Public limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beersel.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0465.345.721

Incorporation

27/01/1999

Legal form

Public limited company

Registered office

Danislaan 13
1650 Beersel · FlandreSee on map

Contributed capital

61 973,38 €

Latest accounts

30/06/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	113,6 k €	-8.8%	124,6 k €	+5.4%	118,2 k €	-25.6%	159 k €	-2.2%	162,5 k €	+32.6%	122,5 k €	+360%	26,6 k €	-78.0%	121,2 k €	+114%	56,6 k €	-37.1%	90 k €	-32.1%	132,5 k €	-0.3%	132,9 k €	-7.3%	143,4 k €	+6.8%	134,3 k €	+25.1%	107,3 k €	+31.7%	81,5 k €	-29.4%	115,5 k €	+28.9%	89,6 k €	-7.3%	96,7 k €
EBITDA	104,5 k €	-11.1%	117,5 k €	+5.6%	111,3 k €	-27.7%	154 k €	-1.8%	156,8 k €	+32.0%	118,8 k €	+432%	22,3 k €	-80.9%	117,2 k €	+123%	52,6 k €	-23.3%	68,5 k €	-36.4%	107,8 k €	+3.4%	104,2 k €	+16.6%	89,4 k €	-9.5%	98,8 k €	+30.9%	75,5 k €	+52.3%	49,5 k €	-40.7%	83,5 k €	+41.3%	59,1 k €	-11.8%	67 k €
Operating result	89,5 k €	-14.3%	104,5 k €	+3.2%	101,2 k €	-29.8%	144,1 k €	+4.2%	138,4 k €	+46.8%	94,3 k €	+534%	-21,7 k €	-130%	73,1 k €	+667%	9,5 k €	-68.8%	30,6 k €	-59.6%	75,6 k €	+4.2%	72,6 k €	+26.3%	57,4 k €	-14.6%	67,3 k €	+28.3%	52,4 k €	+95.0%	26,9 k €	-29.8%	38,3 k €	+178%	13,8 k €	-14.1%	16 k €
Net result	71,7 k €	-12.9%	82,3 k €	+12.7%	73,1 k €	-27.6%	101 k €	+3.5%	97,5 k €	+36.3%	71,6 k €	+330%	-31,1 k €	-173%	42,5 k €	+849%	-5,7 k €	-133%	17,4 k €	-64.3%	48,8 k €	-0.4%	49 k €	+26.5%	38,7 k €	-4.7%	40,6 k €	+52.5%	26,6 k €	+94.2%	13,7 k €	-19.3%	17 k €	+4139%	-420,9 €	-111%	3,7 k €
Balance sheet
Equity	784,1 k €	+10.1%	712,4 k €	+13.1%	630,1 k €	+13.1%	557 k €	+22.1%	456 k €	+27.2%	358,5 k €	+24.9%	287 k €	-9.8%	318,1 k €	+15.4%	275,6 k €	-2.0%	281,3 k €	+6.6%	263,9 k €	+22.7%	215,1 k €	+20.8%	178,1 k €	+11.7%	159,4 k €	+14.9%	138,8 k €	+23.8%	112,1 k €	+13.9%	98,4 k €	+20.9%	81,4 k €	-0.5%	81,8 k €
Total assets	866,1 k €	+5.7%	819,5 k €	+10.3%	742,8 k €	-3.5%	770 k €	+19.7%	643,3 k €	+20.7%	532,7 k €	+23.2%	432,3 k €	-16.7%	518,9 k €	+0.7%	515,1 k €	-1.2%	521,6 k €	+3.2%	505,2 k €	+0.2%	504,4 k €	-6.0%	536,8 k €	-3.2%	554,7 k €	+11.2%	498,7 k €	-5.4%	527,1 k €	-3.4%	545,7 k €	-8.3%	595 k €	-6.2%	634,5 k €
Cash	69,9 k €	-51.3%	143,7 k €	+1.4%	141,7 k €	-65.1%	406 k €	+33.4%	304,3 k €	+63.1%	186,5 k €	+81.8%	102,6 k €	-23.9%	134,7 k €	+48.2%	90,9 k €	-26.7%	124 k €	+21.8%	101,7 k €	+78.2%	57,1 k €	-6.2%	60,9 k €	-3.5%	63,1 k €	+37.1%	46 k €	-25.1%	61,5 k €	+39.0%	44,2 k €	-44.2%	79,2 k €	+29.8%	61 k €
Debts	76,2 k €	-24.5%	100,9 k €	-5.8%	107,1 k €	-47.6%	204,2 k €	+10.6%	184,6 k €	+7.8%	171,2 k €	+21.6%	140,8 k €	-28.9%	198 k €	-16.4%	237 k €	-0.4%	237,8 k €	-0.8%	239,8 k €	-16.5%	287,1 k €	-19.5%	356,7 k €	-9.3%	393,3 k €	+9.3%	360 k €	-13.3%	415 k €	-7.2%	447,3 k €	-12.6%	511,8 k €	-7.1%	550,8 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		0,5 ETP	-16.7%	0,6 ETP	-25.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP	0.0%	0,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 12 ended

Active mandates

Danuta Osiadacz

Director

Active

Philippe Vanneste

Director

Active

Ended mandates

Danuta Osiadacz

Managing director · since 28 décembre 2017 · until 28 décembre 2023

Ended

Philippe Vanneste

Managing director · since 28 décembre 2017 · until 28 décembre 2023

Ended

PHILIPPE VANNESTE

Director · since 28 décembre 2017 · until 28 décembre 2023

Ended

Danuta Urszula Osiadacz

Director · since 02 décembre 2017 · until 02 décembre 2023

Ended

At this address

Other companies at this address

Company	CBE no.
Maasdender● Active	0465.059.372

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/01/2026	21/02/2025	30/01/2024	30/01/2023	21/12/2021	29/01/2021
General meeting	26/11/2025	27/11/2024	22/11/2023	23/11/2022	24/11/2021	16/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	26/11/2025	29/01/2026	Dutch	PDF
Abridged model	30/06/2024	27/11/2024	21/02/2025	Dutch	PDF
Abridged model	30/06/2023	22/11/2023	30/01/2024	Dutch	PDF
Abridged model	30/06/2022	23/11/2022	30/01/2023	Dutch	PDF
Abridged model	30/06/2021	24/11/2021	21/12/2021	Dutch	PDF
Abridged model	30/06/2020	16/12/2020	29/01/2021	Dutch	PDF
Abridged model	30/06/2019	18/12/2019	21/01/2020	Dutch	PDF
Abridged model	30/06/2018	19/12/2018	18/01/2019	Dutch	PDF
Abridged model	30/06/2017	13/12/2017	02/01/2018	Dutch	PDF
Abridged model	30/06/2016	23/11/2016	12/12/2016	Dutch	PDF
Abridged model	30/06/2015	25/11/2015	22/01/2016	Dutch	PDF
Abridged model	30/06/2014	26/11/2014	28/11/2014	Dutch	PDF
Abridged model	30/06/2013	18/12/2013	20/02/2014	Dutch	PDF
Abridged model	30/06/2012	19/12/2012	28/02/2013	Dutch	PDF
Abridged model	30/06/2011	14/12/2011	23/02/2012	Dutch	PDF
Abridged model	30/06/2010	15/12/2010	08/03/2011	Dutch	PDF
Abridged model	30/06/2009	16/12/2009	01/02/2010	Dutch	PDF
Abridged model	30/06/2008	26/11/2008	29/12/2008	Dutch	PDF
Abridged model	30/06/2007	19/12/2007	31/01/2008	Dutch	PDF
Abridged model	30/06/2006	13/12/2006	29/01/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 12 ended

Active mandates

Danuta Osiadacz

Director

Active

Philippe Vanneste

Director

Active

Ended mandates

Danuta Osiadacz

Managing director · since 28 décembre 2017 · until 28 décembre 2023

Ended

Philippe Vanneste

Managing director · since 28 décembre 2017 · until 28 décembre 2023

Ended

PHILIPPE VANNESTE

Director · since 28 décembre 2017 · until 28 décembre 2023

Ended

Danuta Urszula Osiadacz

Director · since 02 décembre 2017 · until 02 décembre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates16/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/06/2019
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares15/02/2012
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates15/02/2010
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202571,7 k €↓
2024
Annual accounts 202482,3 k €↑
2023
Annual accounts 202373,1 k €↓
2022
Annual accounts 2022101 k €↑
2021
Annual accounts 202197,5 k €↑
2020
Annual accounts 202071,6 k €↑
2019
Annual accounts 2019-31,1 k €↓
2018
Annual accounts 201842,5 k €↑
2017
Annual accounts 2017-5,7 k €↓
2016
Annual accounts 201617,4 k €↓
2015
Annual accounts 201548,8 k €↓
2014
Annual accounts 201449 k €↑
2013
Annual accounts 201338,7 k €↓
2012
Annual accounts 201240,6 k €↑
2011
Annual accounts 201126,6 k €↑
2010
Annual accounts 201013,7 k €↓
2009
Annual accounts 200917 k €↑
2008
Annual accounts 2008-420,9 €↓
2007
Annual accounts 20073,7 k €
27/01/1999
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Danis Pharma

Overview

What does Danis Pharma do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline